| Zdroj: |
Cancer Weekly; 10/31/2023, p826-826, 1p |
| Abstrakt: |
The F-SHARP is a multi-institutional two-stage Phase I/II clinical trial of salvage focal HDR brachytherapy for LRR prostate cancer enrolling patients at three centres. Keywords: Chicago; State:Illinois; United States; North and Central America; Biochemicals; Biochemistry; Brachytherapy; Cancer; Chemicals; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Oncology; Prostate Cancer; Prostatic Neoplasms; Radiotherapy; Therapy EN Chicago State:Illinois United States North and Central America Biochemicals Biochemistry Brachytherapy Cancer Chemicals Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Oncology Prostate Cancer Prostatic Neoplasms Radiotherapy Therapy 826 826 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. [Extracted from the article] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
